Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study
HLX04 与参考药物贝伐珠单抗联合 XELOX 或 mFOLFOX6 方案一线治疗转移性结直肠癌的疗效、安全性和免疫原性:一项随机、双盲 III 期研究的结果
期刊:BioDrugs
影响因子:6.9
doi:10.1007/s40259-021-00484-9
Qin, Shukui; Li, Jin; Bai, Yuxian; Shu, Yongqian; Li, Wei; Yin, Xianli; Cheng, Ying; Sun, Guoping; Deng, Yanhong; Zhong, Haijun; Li, Yunfeng; Qian, Xiaoping; Zhang, Liangming; Zhang, Jingdong; Chen, Kehe; Kang, Wenying